medigraphic.com

2009, Number 6

<< Back

Cir Cir 2009; 77 (6)

Cartas al Editor

Reyes Fuentes A

Language: Spanish
References: 32
Page: 505-508
PDF size: 31.05 Kb.


Text Extraction

No abstract


REFERENCES

  1. Choi JY, Kim SE, Shin HJ, Kim BT, Kim JH. Brain tumor imaging with 99mTc-tetrofosmin: comparison with Tl-201, 99mTc-MIBI and 18Ffluorodeoxyglucose.J Neurooncol 2000;46: 63-70.

  2. Pauwels EK, McCready VR, Stoot JH, Van Deurzen DF. The mechanism of accumulation of tumor localizing radiopharmaceuticals. Eur J Nucl Med 1998;25:277-305.

  3. Schomäcker K, Schicha H. Use of myocardial imaging agents for tumor diagnosis; a success story? Eur J Nucl Med 2000;27:1845-1863.

  4. Kostakoglu L, Kiratli P, Ruacan S, Hayran M, Emri S, Ergün EL, et al. Association of tumor washout rates and accumulation of technetium-99m- MIBI with expression of P-glycoprotein in lung cancer. J Nucl Med 1998;39: 228-234.

  5. Nosotti M, Santambrogio L, Gasparini M, Baisi A, Bellaviti N, Rosso L. Role of 99mTc-hexakis-2-methoxy-isobutylisonitrile in the diagnosis and staging of lung cancer. Chest 2002;122:1362-1364.

  6. Dadparvar S, Chevres A, Tulchinsky M, Krishna-Badrinath L, Khan AS, Slizofski WJ. Clinical utility of Tc-99M methoxisobutylisonitrile imaging in differentiated thyroid carcinoma. Comparison with thallium-2O1 and I- 131 Na scintigraphy, and serum thyroglobulin quantitation. Eur J Nucl Med Mol I 1995;22:1330-1338.

  7. Basoglu T, Sahin M, Coşkun C, Koparan A, Bernay I, Erkan L. Technetium- 99m-tetrofosmin uptake in malignant lung tumors. Eur J Nucl Med Mol I 1995;22:687-689.

  8. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug- resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993;53:977-984.

  9. Ballinger JR, Muzzammil T, Moore MJ. Technetium-99m-furifosmin as an agent for functional imaging of multidrug resistance in tumors. J Nucl Med 1997;38:1915-1919.

  10. Ballinger JR, Bannerman J, Boxen I, Firby P, Hartman NG, Moore MJ. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug resistant breast tumor cells. J Nucl Med 1996; 37:1578-1582.

  11. Hendrikse NH, Franssen EJ, van der Graaf WT, Vaalburg W, de Vries EG. Visualization of multidrug resistance in vivo. Eur J Nucl Med Mol I 1999;26:283-293.

  12. Sun SS, Hsieh JF, Tsai SC, Ho YJ, Kao CH. Technetium-99m tetrofosmin mammoscintigraphy findings related to the expression of P-glycoprotein mediated multidrug resistance. Anticancer Res 2000;20:1467-1470.

  13. Arbab AS, Koizumi K, Toyama K, Araki T. Uptaker of technetium-99mtetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 1996;37:1551-1556.

  14. Klain M, Maurea S, Cuocolo A, Colao A, Marzano L, Lombardi G. Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutiylisonitrile scans. Eur J Nucl Med 1996;23:1568-1574.

  15. Kresnik E, Gallowitsch H-J, Mikosch, Gomez I, Lind P. Technetium-99m- MIBI scintigraphy of thyroid nodules in an endemic goiter area. J Nucl Med 1997;38:62-65.

  16. Sathekge MM, Mageza RB, Muthuphei MN, Modiba MC, Clauss RC. Evaluation of thyroid nodules with technetium-99m MIBI and technetium- 99m pertechnetate. Head and Neck 2001;23:305-310.

  17. Ding HJ, Huang WT, Tsai CS, Chang CS, Kao A. Usefulness of technetium- 99m tetrofosmin liver imaging to detect hepatocellular carcinoma and related to expression of Pglycoprotein or multidrug resistance associated proteinža preliminary report. Nucl Med Biol 2003;30:471-475.

  18. Kosuda S, Yokoyama H, Katayama M, Yokokawa T, Kusano S, Yamamoto O. Tc-99m tetrofosmin and Tc-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma. Eur J Nucl Med Mol I 1995;22:1218-1220.

  19. Nemec J, Nyvltová O, Preiningerová M, Vlcek P, Racek P, Novák Z, et al. Positive thyroid cancer scintigraphy using Tc-99m-tetrofosmin (myoview). A preliminary report. Nucl Med Commun 1995;16:694-697.

  20. Ishibashi M, Fujimoto K, Ohzono H, Meno S, Hayabuchi N. 99m-Tc tetrofosmin uptake in mediastinal tumours. Br J Radiol 1996;69:1134-1138.

  21. Karanikas G, Köstler WJ, Becherer A, Wiesner K, Dudczak R, Krainer M, et al. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma. Oncol Rep 2002;9:1009-1013, 139.

  22. Rodrigues M, Chehne F, Kalinowska W, Zielinski Ch. Comparative Tc- 99m-MIBI, Tc-99m-tetrofosmin and Tc-99m-furifosmin uptake in human soft tissue sarcoma cell lines. Eur J Nucl Med Mol I 2000;27:1839-1843.

  23. Schillaci O, Spanau A, Scopinaro F, Montelone F, Masala S, Tarantino U, et al. Technetium-99m tetrofosmin scintigraphy in pediatric osteogenic sarcoma. Oncol Rep 2003;10:605-608.

  24. Söderlund V, Jonsson C, Bauer HC, Brosjö O, Jacobsson H. Comparison of technetium-99m- MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas. J Nucl Med 1997;38:682-686.

  25. Schillaci O, Buscombe J. Breast scintigraphy today: indications and limitations. Eur J Nucl Med Mol I 2004;31(suppl1):S35-S45.

  26. Spanu A, Farris A, Schillaci O, Chessa F, Solinas ME, Falchi A, et al. The usefulness of Tc-99m tetrofosmin scintigraphy in patients with breast cancer recurrences. Nucl Med Commun 2003;24:145-154, 144.

  27. Rambaldi PF, Mansi L, Procaccini E, Di Gregorio F, Del Vecchio E. Breastcancer detection with Tc-99m tetrofosmin. Clin Nucl Med 1995;20:703-705.

  28. Mansi L, Rambaldi PF, Procaccini E, Gregorio FD, Laprovitera A, Pecori B, et al. Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases. Eur J Nucl Med Mol I 1996;23:932-939.

  29. 29.Tabuenca MJ, Vargas JA, Varela A, Salas C, Ramón y Cajal S, Durántez A, et al. Inverse correlation between Tc-99m tetrofosmin uptake and Pglycoprotein in non-small cell lung cancer. J Nucl Med 1999;40:1223-1224.

  30. 30.Tabuenca MJ, Vargas JA, Varela A, Salas C, Durántez A, Ortiz-Berrocal J. Technetium-99m-tetrofosmin scintigraphy, P-glycoprotein and lung cancer. J Nucl Med 1998;39:1830-1831.

  31. Fuster D, Vińolas N, Mallafre C, Pavia J, Martin F, Pons F. Tetrofosmin as predictor of tumour response. Q J Nucl Med 2003;47:58-62.

  32. Basoglu T, Bernay I, Coskun C, Canbaz F, Talu A, Erkan L. Pulmonary Tc- 99m tetrofosmin imaging: clinical experience with detecting malignant lesions and monitoring response to therapy. Clin Nucl Med 1998;23:753-757.




2020     |     www.medigraphic.com